Mercelis R - Search Results

1

Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study.

Antozzi C, Guptill J, Bril V, Gamez J, Meuth SG, Nowak RJ, Quan D, Sevilla T, Jouvin MH, Jin J, Karcher K, Ramchandren S, Sun H, Ling L, Zhu Y, Arroyo S; Vivacity-MG Phase 2 Study Group. Antozzi C, et al. Neurology. 2024 Jan 23;102(2):e207937. doi: 10.1212/WNL.0000000000207937. Epub 2023 Dec 21. Neurology. 2024. PMID: 38165333 Free PMC article. Clinical Trial.

2

Current management of myasthenia gravis in Belgium: a single-center experience.

Mercelis R, Alonso-Jiménez A, Van Schil P. Mercelis R, et al. Acta Neurol Belg. 2023 Apr;123(2):375-384. doi: 10.1007/s13760-023-02187-0. Epub 2023 Jan 20. Acta Neurol Belg. 2023. PMID: 36658451 Free PMC article. Review.

3

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F; REGAIN Study Group. Siddiqi ZA, et al. Muscle Nerve. 2021 Dec;64(6):662-669. doi: 10.1002/mus.27422. Epub 2021 Oct 14. Muscle Nerve. 2021. PMID: 34590717 Clinical Trial.

4

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.

Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.

5

Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months.

Masrori P, Vaesen Bentein H, Raskin J, Montagna M, De Picker L, De Volder I, Van Schil PE, Janssens A, Mercelis R. Masrori P, et al. Among authors: mercelis r. Lung Cancer. 2021 Mar;153:117-119. doi: 10.1016/j.lungcan.2021.01.012. Epub 2021 Jan 13. Lung Cancer. 2021. PMID: 33485137

6

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr; REGAIN Study Group. Mantegazza R, et al. Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23. Neurology. 2021. PMID: 33229455 Free PMC article. Clinical Trial.

7

Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr; REGAIN study group. Mantegazza R, et al. Ann Clin Transl Neurol. 2020 Aug;7(8):1327-1339. doi: 10.1002/acn3.51121. Epub 2020 Jul 22. Ann Clin Transl Neurol. 2020. PMID: 32700461 Free PMC article. Clinical Trial.

8

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF; REGAIN study group. Vissing J, et al. J Neurol. 2020 Jul;267(7):1991-2001. doi: 10.1007/s00415-020-09770-y. Epub 2020 Mar 18. J Neurol. 2020. PMID: 32189108 Free PMC article. Clinical Trial.

9

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.

Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Suzuki H, Okumura M, O'Brien F, Wang JJ, Fujita KP, Utsugisawa K; REGAIN Study Group. Murai H, et al. J Neurol Sci. 2019 Dec 15;407:116419. doi: 10.1016/j.jns.2019.08.004. Epub 2019 Aug 3. J Neurol Sci. 2019. PMID: 31698177 Free article.

10

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.

Colosimo C, Charles D, Misra VP, Maisonobe P, Om S; INTEREST IN CD2 study group. Colosimo C, et al. J Neurol. 2019 Dec;266(12):3047. doi: 10.1007/s00415-019-09549-w. J Neurol. 2019. PMID: 31595379 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters